MARKET

MYOS

MYOS

MYOS RENS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9400
+0.0300
+3.30%
Closed 16:00 04/01 EDT
OPEN
0.9000
PREV CLOSE
0.9100
HIGH
0.9503
LOW
0.9000
VOLUME
8.18K
TURNOVER
--
52 WEEK HIGH
1.800
52 WEEK LOW
0.7412
MARKET CAP
10.21M
P/E (TTM)
-1.9385
1D
5D
1M
3M
1Y
5Y

Analyst Price Target

The average MYOS stock price target is 3.750 with a high estimate of 3.750 and a low estimate of 3.750.

EPS

MYOS News

More
  • Edited Transcript of MYOS earnings conference call or presentation 25-Mar-20 3:00pm GMT
  • Thomson Reuters StreetEvents · 3d ago
  • MYOS RENS Technology Inc (MYOS) CEO Joseph Mannello on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/25 18:04
  • MYOS RENS Technology beats on revenue
  • seekingalpha · 03/25 15:09
  • MYOS RENS Technology, Inc. to Host Earnings Call
  • ACCESSWIRE · 03/25 14:00

Industry

Food Processing
-2.13%
Food & Tobacco
-1.81%

Hot Stocks

Symbol
Price
%Change

About MYOS

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
More

Webull offers kinds of MYOS RENS Technology Inc stock information, including NASDAQ:MYOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYOS stock news, and many more online research tools to help you make informed decisions.